Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Tirzepatide Versus Placebo or Lisdexamfetamine Dimesylate for Binge-Eating Disorder: A Randomized Clinical Trial

NCT06847399 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.

NCT NCT06847399
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06847399 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Tirzepatide Versus Placebo or Lisdexamfetamine Dimesylate for Binge-Eating Disorder: A Randomized Clinical Trial
Lead sponsor
Johns Hopkins University
Phase
Phase 2
Overall status
Recruiting
Start date
September 17, 2025
Completion date
December 1, 2027
Enrollment
105 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

binge eating disorder, obesity and overweight